Wuhan Zonke Optoelectronic Technology Co., Ltd.
News Center
[ZKKL] Academic Presentation | Comparative Efficacy of Radiofrequency and Surgical Treatments for Axillary Odor
Release time:2019-11-14
Reprinted from: Chinese Journal of Dermatology and Venereology, Issue 12, 2017, p. 1324.
Authors: Yang Wanjun, Liu Lihua, Wu Si
[Abstract] Axillary osmidrosis is a common clinical condition, particularly prevalent among young women, with its hallmark symptom being an unpleasant, pungent odor emanating from the axillary region. This condition imposes a significant psychological burden on patients, which is why treatment for axillary osmidrosis is frequently performed in plastic surgery.
Currently, treatment options for axillary osmidrosis primarily include surgical and non‑surgical approaches; however, these methods differ substantially in terms of cure rates, recurrence rates, and the incidence of complications. In this study, we employed radiofrequency ablation and surgical excision to treat patients with axillary osmidrosis, comparing the efficacy and complication profiles of the two modalities to provide evidence‑based guidance for clinical practice.
[Keywords] Body odor from the armpits 、 Treatment 、 Disease
-
1
-
Materials and Methods
1. 1 General Information Select 2015 4 Month – 2016 Year 4 The patient visited the outpatient department and
A total of 54 patients diagnosed with axillary osmidrosis were enrolled as the study subjects, including males. 16 Example, female 38 Example ; Age 18 ~ 43 Age, average ( 25. 4 ± 3. 2) Year. Refer to Park The grading criteria for axillary osmidrosis, 14 For example, a patient classified as Grade II, 40 For example, patients classified as Grade III. Inclusion criteria : ① All patients were clinically diagnosed with axillary osmidrosis and were classified as Grade II to III. ; ② The patient or their family member signs an informed consent form, and the study is approved by the hospital’s ethics committee. Exclusion criteria: : ① The patient has no keloids or hypertrophic scars at the axillary surgical site. ; ② Presence of cardiovascular disease, severe hepatic or renal disease, psychosomatic disorders, coagulation disorders, or implants in the surgical area. ; ③ Pregnant women, and patients with erythema, swelling, warmth, pain, infection, or ulceration in the axillary surgical area. ; ④ Patients with a history of anesthesia allergy or those who are menstruating. Patients were randomly assigned to two groups—surgical group and radiofrequency ablation group—using a random number table; no statistically significant differences were observed between the two groups in terms of age, sex, disease severity, or other baseline characteristics. ( P All > 0. 05) , which are comparable; see the table. 1。
1. 2 Treatment methods Surgical group: W‑shaped incision with subcutaneous trimming; the patient is positioned supine, with both upper limbs flexed at the elbows and abducted, and both hands placed above the head, along the outer border of the axillary hair. 0. 5 cm Mark the surgical area and prepare the skin. 0. 5% Disinfect the surgical site with povidone‑iodine, then drape the patient according to standard procedure. 0. 5% Lidocaine with epinephrine ( 1 ∶ 200,000) Administer local infiltration anesthesia, “ W “The incision is made along the axillary hairline at the intersection of the transverse axillary crease and the posterior axillary line, with the length determined by the extent of the surgical procedure. The skin is incised, and the preoperative marked area in the axilla is dissected. Traction sutures are placed along the incision margins, the skin flap is reflected, and the subcutaneous adipose tissue, hair follicles, apocrine sweat glands, eccrine sweat glands, sebaceous glands, and other structures beneath the flap are excised, while preserving the subdermal vascular plexus and achieving hemostasis with electrocautery. The subflap space is irrigated repeatedly with saline, a subcutaneous drain is routinely placed, and the incision is closed. A packing suture is applied around the operative site, followed by a compressive dressing consisting of Vaseline‑impregnated gauze, cotton balls, and an elastic bandage. Postoperatively, antibiotics and hemostatic agents are administered, and both upper limbs are immobilized; on postoperative day… ” 2 Change the dressing, remove the drainage skin flap, and continue compression bandaging with an elastic bandage. On postoperative day… 7 Open the pressurization pack, item No. 10 Sutures removed. Radiofrequency group. : Bodytite Radiofrequency therapy: The patient lies supine with both arms abducted and hands clasped behind the head. Use methylene blue to delineate the axillary hair‑bearing area, extending the marked boundary beyond the natural edge of the axillary hair. 2cm , routine disinfection and draping. Use 0. 5% Lidocaine swelling solution for local tumescent anesthesia, with subcutaneous injection on each side. 30 ~ 40mL . Use the metal cannula of the gold microneedle radiofrequency treatment device to perform superficial puncture in the subcutaneous fat layer of the treatment area, then connect. Connect the handpiece to the main unit and turn on the treatment device. Select appropriate radiofrequency parameters based on the patient’s skin thickness, and set the target temperature. Apply a sterile gel evenly over the treatment area and its surroundings, gently press the external receiving electrode to ensure close contact with the skin, and deliver treatment by moving slowly while applying localized “stamping” motions; at each stamping point, a distinct “crackling sound” will be heard. ( Less than 2s) , allowing the energy to penetrate beneath the epidermis to the preset temperature; at this point, the treatment endpoint is reached. The device is then slowly moved to the next treatment site, with an interval of approximately 1. 3 cm , covering the entire target area for treatment. During the procedure, a refrigerated epidermal growth factor spray was applied; postoperatively, the wound surface was topically treated with a compound polymyxin preparation and an epidermal growth factor spray, followed by ice‑pack cryotherapy for 30 minutes.
1. 3 Efficacy Evaluation Criteria Home visits or telephone follow-ups for 6 months ~ 2 Year, average 15 Over a period of months, assessments should include wound bleeding, hematoma, infection, necrosis, and ulceration; whether postoperative odor has changed or recurred; and the presence of hypertrophic scarring. Criteria for evaluating treatment efficacy are as follows: : Recovery is defined as the distance from the patient. 1m No odor is detected in any state. ; The effective distance is from the patient. 1m A slight odor is present, or it is only detectable after physical exertion. ; Invalid as it is distant from the axilla. 1m The smell can be detected either inside or outside. ; Recurrence refers to the reappearance of axillary odor in patients who have previously achieved complete recovery following treatment. Efficacy rate: = ( Number of cured cases + Number of cases with marked efficacy ) / Total number of cases, recurrence rate = Number of relapse cases / Number of cured cases.
1. 4 Statistical analysis SPSS 17.0 software was used; categorical data are presented as percentages, and χ 2 The test was conducted for between-group comparisons. P < 0. 05 The difference was statistically significant.
-
2
-
Result
Treatment outcomes The treatment efficacy rates for the two patient groups were 84.62% and 85. 71% , the recurrence rates of the two groups were respectively 22. 22% and 22. 22% , there were no statistically significant differences between the two groups in either the effective rate or the recurrence rate. ( chi 2= 6. 78 , P = 0.71; chi 2= 6.59, P = 0.74) , see Table 2。
2. 2 Complications The complication rate in the radiofrequency group was 11.54%, significantly lower than that in the surgical group. 25. 00% , the difference is statistically significant ( chi 2= 1. 64 , P = 0.03) , see Table 3。
-
3
-
Discussion
The prevalence of axillary osmidrosis in the Chinese population is as high as 6.41%, making it a common condition in cosmetic and plastic surgery; however, no study has yet clearly elucidated its pathogenesis. The development of axillary osmidrosis is associated with abnormal secretory function of the apocrine sweat glands, which, influenced by genetic and endocrine factors, typically increase markedly during puberty and subsequently atrophy with aging, leading to a corresponding reduction in odor. Individuals with axillary osmidrosis experience substantial psychological and physical burdens in social interactions; therefore, there is an urgent need for treatment modalities that are simple, minimally invasive, aesthetically pleasing, allow rapid recovery, and deliver long-lasting results.
At present, conventional treatments for axillary osmidrosis are diverse, each with its own advantages and disadvantages. Topical medications and injectable therapies alleviate body odor by inhibiting apocrine sweat gland secretion; while they offer rapid relief, quick recovery, minimal discomfort, and limited invasiveness, their effects are short-lived because the apocrine glands remain intact, necessitating repeated sessions to maintain results. Surgical approaches aimed at removing the apocrine glands provide more definitive outcomes—for example, axillary skin excision. Although this method can achieve a permanent cure, the substantial postoperative trauma often leads to hypertrophic scarring and, in some cases, scar contracture.
With the continuous advancement of medical technology, minimally invasive techniques such as small‑incision subcutaneous trimming, small‑incision curettage and suction, and aspiration are being increasingly employed. These procedures offer significant advantages, including minimal trauma and rapid recovery; however, because they rely on blind removal of apocrine sweat glands, they are prone to incomplete excision, which may lead to complications such as infection, hematoma, and skin necrosis.
The radiofrequency therapeutic device utilizes the reciprocating flow of radiofrequency current between the transmitting and receiving electrodes, combined with the electrical resistance generated by the tissue, to induce frictional heating of water molecules within the tissue, thereby ablating cells. ; Alternatively, the thermal effect can induce protein denaturation within the cells of the apocrine sweat glands, leading to cell lysis and thereby achieving the goal of removing these glands.
This study employed both radiofrequency ablation and surgical excision to treat patients with axillary osmidrosis, comparing the efficacy and incidence of complications between the two approaches. The results indicated that, compared with radiofrequency therapy, surgical treatment showed no statistically significant differences in either therapeutic efficacy or recurrence rate. ( P All > 0. 05) ; However, the incidence of complications in patients undergoing radiofrequency ablation was significantly lower than that in patients undergoing surgical treatment, with a statistically significant difference. ( P < 0. 05) 。 The results indicate that radiofrequency treatment for axillary osmidrosis is comparable in efficacy to conventional surgical therapy; however, radiofrequency ablation is easier to perform, has fewer contraindications, offers improved safety, and is less likely to leave scars, thereby preserving postoperative cosmetic outcomes. ; Surgical treatment, by contrast, inflicts greater trauma on patients and is prone to postoperative complications such as infection, scarring, and skin necrosis, which not only compromise cosmetic outcomes but may also impose functional limitations on the upper limb. Zhang Zhiping et al. have likewise reported that both surgical and radiofrequency ablation achieve cure rates approaching 70%, with no significant difference in efficacy; however, surgical intervention often entails postoperative complications, including scarring.
However, Zhu Guang also indicated that radiofrequency therapy yields significantly better outcomes than surgical treatment in patients with axillary osmidrosis. It also points out that radiofrequency ablation is associated with fewer complications and better safety; the reasons for the differing conclusions may largely stem from variations in the specific surgical techniques employed. At present, there are few reports on post‑treatment recurrence rates following either approach. This study indicates that the recurrence rate after both treatments was 22. 22% Although there is no significant difference between the two, the recurrence rates remain high—this remains a pressing concern for many patients and clinicians. These findings underscore the need for further research and refinement in the treatment of axillary osmidrosis, with the aim of helping patients more effectively address this condition and promptly alleviate the distress and burden it imposes.
In summary, radiofrequency therapy for axillary osmidrosis is easy to perform, highly effective, minimally invasive, associated with few complications, and offers long-lasting, reliable results.
Note: This article is intended for academic exchange only and may not be used for commercial purposes. Copyright belongs to the original author; if any infringement occurs, please contact us immediately, and we will address it promptly.
ZKKL- Gold‑microneedle radiofrequency treatment is designed with a combination of a microneedle probe, radiofrequency energy, and the fractional‑laser technology. The microneedle probe features “gold‑coated micro‑needles” just 0.12 mm in diameter, which penetrate deep into the skin while simultaneously delivering nourishing ingredients to the surface for enhanced penetration. Once inside the dermis, these gold micro‑needles operate like a precision system: they deliver instantaneous micro‑vibrations to facilitate insertion, and within 0.1 seconds release radiofrequency energy directly from their tips, ensuring complete energy delivery to the dermal layer. This promotes effective protein denaturation and remodeling, stimulating collagen production. Beyond effectively stimulating the regeneration and reorganization of deep‑lying collagen—addressing signs of aging such as wrinkles and sagging—and treating axillary odor, this treatment also helps protect the epidermis and reduces the risk of thermal injury.
Wuhan Zhongke Keli
Wuhan Zhongke Keli adheres to the business philosophy of “excellence in technology, success through sound principles,” continuously strengthening technological and managerial innovation, and steadfastly providing customers with high-quality products and services.
Dedicated to high-end medical aesthetic equipment for 30 years.
CAS KeLi
Consultation phone: 027-87778667, 18064007016
Official website: www.zonkelaser.com
Official website: www.zonkel.com.cn
Related News